CD8A and neoplasm: In tumors that received either T cell treatment, there was an increase in PDL1+ MHCI+ tumor cells, whereas there were less than 2% inflamed tumor cells in the control tumors, associated with higher levels of CD8+ T cells (Figures 4D and S6).